Seliciclib is under clinical development by Cyclacel Pharmaceuticals and currently in Phase II for Rheumatoid Arthritis. According to GlobalData, Phase... Likelihood of Approval and Phase Transition ...
ELVN-002 is under clinical development by Enliven Therapeutics and currently in Phase I for Non-Small Cell Lung Cancer. According to... Likelihood of Approval and Phase Transition Success Rate Model - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback